Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Codexis (CDXS) Cash & Equivalents (2016 - 2025)

Codexis has reported Cash & Equivalents over the past 16 years, most recently at $50.8 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $50.8 million for Q4 2025, up 163.67% from a year ago — trailing twelve months through Dec 2025 was $50.8 million (up 163.67% YoY), and the annual figure for FY2025 was $50.8 million, up 163.67%.
  • Cash & Equivalents for Q4 2025 was $50.8 million at Codexis, up from $25.4 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for CDXS hit a ceiling of $139.7 million in Q1 2021 and a floor of $18.3 million in Q1 2025.
  • Median Cash & Equivalents over the past 5 years was $82.3 million (2022), compared with a mean of $75.1 million.
  • Biggest five-year swings in Cash & Equivalents: crashed 79.81% in 2024 and later soared 163.67% in 2025.
  • Codexis' Cash & Equivalents stood at $116.8 million in 2021, then decreased by 2.41% to $114.0 million in 2022, then plummeted by 42.87% to $65.1 million in 2023, then plummeted by 70.42% to $19.3 million in 2024, then soared by 163.67% to $50.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $50.8 million (Q4 2025), $25.4 million (Q3 2025), and $26.8 million (Q2 2025) per Business Quant data.